Nicholas Good

Nicholas Good is an executive vice president and chief growth and strategy officer for State Street

Nicholas Good

Nick is an Executive Vice President and Chief Growth and Strategy Officer for State Street. In this role, Nick is responsible for developing long-term business growth and new sources of earnings for State Street. His responsibilities include strengthening business partnerships, driving continued innovation, setting overall business strategy and leading M&A activities. Nick works closely with the Management Committee and Board of Directors.

Prior to this role, Nick spent two years as Co-Head of State Street Global Advisor's Global SPDR Business, with primary responsibility for the North America and Latin America regions, comprising $600B of AUM. During his tenure, US SPDR revenue grew from $359M in 2015 to $491M in 2017. Nick also championed a number of significant initiatives and client wins, most notably the launch of the SPDR Portfolio Series, SSGA’s ultra-low-cost ETFs in partnership with TD Ameritrade, raising over $10B in its first four months. Nick initially joined State Street Global Advisors in 2014 as Chief Operating Officer of the US Intermediary Business Group with responsibility for strategic client relationships, investment and market outlooks as well as sales planning and support for SPDR ETFs in the US. Nick was a member of State Street Global Advisor's Executive Management Group.

Prior to joining State Street, Nick spent 8 years with BlackRock, primarily as CEO of iShares, an Asia Pacific company based in Hong Kong, where he was responsible for both distribution and management of iShares ETFs across 8 offices across the region. During his tenure, iShares Asia Pacific grew from US$20M to US$170M in revenue, rising from #4 to #1 in the region. Before joining Barclays Global Investors (BGI), which merged with BlackRock in 2009, Nick was a lead client manager at the Boston Consulting Group based in San Francisco.

Nick is a graduate of Oxford University, where he studied biochemistry.